Louis H. Philipson
Affiliations: | University of Chicago, Chicago, IL |
Area:
Molecular Biology, Neuroscience Biology, General BiophysicsGoogle:
"Louis Philipson"Mean distance: 106866
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Haliyur R, Walker JT, Sanyoura M, et al. (2021) Integrated Analysis of the Pancreas and Islets Reveals Unexpected Findings in Human Male With Type 1 Diabetes. Journal of the Endocrine Society. 5: bvab162 |
Herold KC, Reynolds J, Dziura J, et al. (2020) Exenatide ER in patients with Type 1 diabetes with and without residual insulin production. Diabetes, Obesity & Metabolism |
Chung WK, Erion K, Florez JC, et al. (2020) Precision Medicine in Diabetes: A Consensus Report From the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 43: 1617-1635 |
Chung WK, Erion K, Florez JC, et al. (2020) Precision medicine in diabetes: a Consensus Report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia |
Pratley RE, Kanapka LG, Rickels MR, et al. (2020) Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial. Jama. 323: 2397-2406 |
Philipson LH. (2020) Harnessing heterogeneity in type 2 diabetes mellitus. Nature Reviews Endocrinology. 16: 79-80 |
Harris A, Naylor RN, Sanyoura M, et al. (2020) 178-LB: Insights from the University of Chicago Monogenic Diabetes Registry on Diagnosis and Management of Monogenic Diabetes Diabetes. 69 |
Zhang H, Maloney KA, Barbetti F, et al. (2020) 1453-P: Adaption of the ACMG/AMP Variant Interpretation Guidelines for GCK, HNF1A, HNF4A-MODY: Recommendations from the ClinGen Monogenic Diabetes Expert Panel Diabetes. 69 |
Virostko J, Williams JM, Hilmes MA, et al. (2020) 1283-P: Multicenter Assessment of the Pancreas in Type 1 Diabetes (MAP-T1D) Diabetes. 69 |
Herold KC, Reynolds J, Dziura J, et al. (2020) Author response for "Exenatide ER in patients with Type 1 diabetes with and without residual insulin production" Diabetes, Obesity and Metabolism |